Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Revenue: 2024-2025

Historic Revenue for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $20.8 million.

  • Kura Oncology's Revenue rose 5136.41% to $20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year change of. This contributed to the annual value of $53.9 million for FY2024, which is 3578.57% up from last year.
  • Per Kura Oncology's latest filing, its Revenue stood at $20.8 million for Q3 2025, which was up 35.73% from $15.3 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Revenue ranged from a high of $20.8 million in Q3 2025 and a low of -$412,000 during Q3 2024.